Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Buys 117,417 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 11.9% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,106,536 shares of the pharmacy operator’s stock after acquiring an additional 117,417 shares during the quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Walgreens Boots Alliance were worth $24,609,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Candriam Luxembourg S.C.A. boosted its position in shares of Walgreens Boots Alliance by 0.5% during the first quarter. Candriam Luxembourg S.C.A. now owns 63,483 shares of the pharmacy operator’s stock worth $2,842,000 after acquiring an additional 310 shares during the last quarter. Signet Financial Management LLC boosted its position in shares of Walgreens Boots Alliance by 1.0% during the first quarter. Signet Financial Management LLC now owns 35,461 shares of the pharmacy operator’s stock worth $1,588,000 after acquiring an additional 334 shares during the last quarter. Roman Butler Fullerton & Co. boosted its position in shares of Walgreens Boots Alliance by 3.3% during the second quarter. Roman Butler Fullerton & Co. now owns 10,660 shares of the pharmacy operator’s stock worth $319,000 after acquiring an additional 336 shares during the last quarter. Pinnacle Financial Partners Inc boosted its position in shares of Walgreens Boots Alliance by 3.5% during the second quarter. Pinnacle Financial Partners Inc now owns 9,940 shares of the pharmacy operator’s stock worth $283,000 after acquiring an additional 336 shares during the last quarter. Finally, Vantage Consulting Group Inc lifted its position in Walgreens Boots Alliance by 1.7% during the second quarter. Vantage Consulting Group Inc now owns 20,759 shares of the pharmacy operator’s stock valued at $591,000 after purchasing an additional 344 shares during the last quarter. Institutional investors own 57.92% of the company’s stock.

Walgreens Boots Alliance Price Performance

Walgreens Boots Alliance stock opened at $22.76 on Wednesday. The firm has a 50-day moving average price of $23.51 and a 200-day moving average price of $24.01. The firm has a market capitalization of $19.63 billion, a PE ratio of 34.48, a price-to-earnings-growth ratio of 1.39 and a beta of 0.75. The company has a current ratio of 0.66, a quick ratio of 0.30 and a debt-to-equity ratio of 0.27. Walgreens Boots Alliance, Inc. has a 12-month low of $19.68 and a 12-month high of $37.96.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last posted its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $0.66 EPS for the quarter, topping the consensus estimate of $0.62 by $0.04. The company had revenue of $36.70 billion for the quarter, compared to the consensus estimate of $34.95 billion. Walgreens Boots Alliance had a net margin of 0.40% and a return on equity of 10.48%. The firm’s revenue was up 9.9% compared to the same quarter last year. During the same quarter last year, the firm posted $1.16 EPS. As a group, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 3.28 EPS for the current year.

Walgreens Boots Alliance Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 12th. Investors of record on Tuesday, February 20th will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 4.39%. The ex-dividend date of this dividend is Friday, February 16th. Walgreens Boots Alliance’s dividend payout ratio is presently 290.91%.

Wall Street Analysts Forecast Growth

Several research firms have commented on WBA. Truist Financial lowered their price objective on shares of Walgreens Boots Alliance from $30.00 to $25.00 and set a “hold” rating for the company in a research report on Wednesday, October 11th. Mizuho lowered their price objective on shares of Walgreens Boots Alliance from $31.00 to $25.00 and set a “neutral” rating for the company in a research report on Tuesday, October 10th. Barclays began coverage on shares of Walgreens Boots Alliance in a research report on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 price objective for the company. Royal Bank of Canada lowered their price objective on shares of Walgreens Boots Alliance from $29.00 to $26.00 and set a “sector perform” rating for the company in a research report on Friday, October 13th. Finally, TheStreet upgraded shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research report on Monday, January 8th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus price target of $28.25.

View Our Latest Stock Report on WBA

Insider Buying and Selling

In related news, Director Nancy M. Schlichting sold 15,209 shares of the firm’s stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $23.05, for a total value of $350,567.45. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In related news, Director Nancy M. Schlichting sold 15,209 shares of the firm’s stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $23.05, for a total value of $350,567.45. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Timothy C. Wentworth bought 10,000 shares of the business’s stock in a transaction on Friday, January 5th. The shares were acquired at an average cost of $24.22 per share, for a total transaction of $242,200.00. Following the transaction, the chief executive officer now directly owns 585,122 shares in the company, valued at approximately $14,171,654.84. The disclosure for this purchase can be found here. 17.40% of the stock is currently owned by insiders.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Articles

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.